Dergiler / The Journal of Breast Health / 2016 / Cilt: 12 - Sayı: 1

Male Breast Cancer

Sayfa
1–8
Yayın Tarihi
2022-10-18
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

This review emphasizes the incidence, etiology, clinical features, diagnosis, treatment, pathology, survival, and prognostic factors related to MBC.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Male breast cancer (MBC) is a rare disease, accounting for less than 1% of all breast cancer diagnoses worldwide.
📊
Temel Bulgular & Veri:Although breast carcinomas share certain characteristics in both genders, there are notable differences.
💡
Sonuç & Katkı:This review emphasizes the incidence, etiology, clinical features, diagnosis, treatment, pathology, survival, and prognostic factors related to MBC.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Male breast cancer (MBC) is a rare disease, accounting for less than 1% of all breast cancer diagnoses worldwide. Although breast carcinomas share certain characteristics in both genders, there are notable differences. Most studies on men with breast cancer are very small. Thus, most data on male breast cancer are derived from studies on females. However, when a number of these small studies are grouped together, we can learn more from them. This review emphasizes the incidence, etiology, clinical features, diagnosis, treatment, pathology, survival, and prognostic factors related to MBC.

🔖

Bu Makaleye Atıf Yap

YALAZA, M., BOZER, M., İNAN, A. (2022). Male Breast Cancer. The Journal of Breast Health, Cilt: 12 - Sayı: 1, 1–8. https://ajindex.com/articles/597846

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (2)

  1. Giardano SH. A review of the diagnosis and management of male breast cancer. Oncologist 2005; 10:471-479. (PMID: 16079314) [CrossRef] 2. Crew KD, Neugut AI, Wang X, Jacobson JS, Grann VR, Raptis G, Hershman DL. Racial disparities in treatment and survival of male breast cancer. J Clin Oncol 2007; 25:1089-1098. (PMID: 17369572) [CrossRef] 3. National Cancer Institute, Surveillance, Epidemiology, and End Results Program SEER Cancer Statistics Review, 1975-2011. Available from: http://seer.cancer.gov/csr/1975_2011/browse_csr.php?sectionSEL=4&pa geSEL=sect_04_table.05.html. 4. Sasco AJ, Lowenfels AB, Pasker-de Jong P. Review article: epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected aetiological factors. Int J Cancer 1993;53: 538-549. (PMID:8436428) [CrossRef] 5. Brinton LA, Richesson DA, Gierach GL, Lacey JV, Park Y, Hollenbeck AR, Schatzkin A. Prospective evaluation of risk factors for male breast cancer. J Natl Cancer Inst 2008; 100:1477-1481. (PMID: 18840816) [CrossRef] 6. International Agency for Research on Cancer. GLOBOCAN 2012.
  2. Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. Available from: http://globocan.iarc.fr/pages/online.aspx 7. Cutuli B, Lacroze M, Dilhuydy JM, Velten M, De Lafontan B, Marchal C, Resbeut M, Graic Y, Campana F, Moncho-Bernier V. Male breast cancer: results of the treatments and prognostic factors in 397 cases. Eur J Cancer 1995; 31A: 1960-1964. (PMID: 8562148) [CrossRef] 8. Cutuli B, Le-Nir CC, Serin D, Kirova Y, Gaci Z, Lemanski C, De Lafontan B, Zoubir M, Maingon P, Mignotte H, de Lara CT, Edeline J, Penault-Llorca F, Romestaing P, Delva C, Comet B, Belkacemi Y. Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases. Crit Rev Oncol Hematol 2010; 73:246-254. (PMID: 19442535) [CrossRef] 9. Oger AS, Boukerrou M, Cutuli B, Campion L, Rousseau E, Bussières E, Raro P, Classe JM. Male breast cancer: prognostic factors, diagnosis and treatment: a multi-institutional survey of 95 cases. Gynecol Obstet Fertil 2015; 43:290-296. (PMID: 25818033) [CrossRef] 10. Fentiman IS, Fourquet A, Hortobagyi GN. Male breast cancer. Lancet 2006; 367:595-604. (PMID: 16488803). [CrossRef] 11. Weiss JR, Moysich KB, Swede H. Epidemiology of male breast cancer. Cancer Epidemiol Biomarkers Prev 2005; 14:20-26. (PMID:15668471) 12. Surveillance, Epidemiology, and End Results (SEER) Program. Public-use data (1993–1997). Bethesda (MD): Natio